Herceptin 150 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJH8V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,830
Award facts
- Contract value 100% obligated
- $10,829.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,829.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials on January 14, 2026, with an ultimate completion date of February 5, 2026. This competitively awarded delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Herceptin (trastuzumab) is a monoclonal antibody therapeutic used in oncology treatment, reflecting the pharmaceutical supplier's critical role in supporting military healthcare needs.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2031. This comprehensive IDC serves as the primary vehicle enabling Cencora and its subsidiary AmerisourceBergen to deliver a full range of pharmaceutical products and medical supplies—including specialty medications, vaccines, and medical devices—to support military treatment facilities and veteran healthcare programs globally. The contract structure demonstrates the vendor's established capacity to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJH8V?
SPE2DR26FJH8V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH8V worth?
The government has obligated $10,830 on SPE2DR26FJH8V.
Is contract SPE2DR26FJH8V an order under another contract?
Yes. SPE2DR26FJH8V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH8V competed?
The extent of competition for SPE2DR26FJH8V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award